Literature DB >> 30847533

[Universal genetic testing to combat underdiagnosis of hereditary breast cancer].

Marciana Nona Duma1, Andrea Wittig2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30847533     DOI： 10.1007/s00066-019-01448-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Precision medicine meets public health: population screening for BRCA1 and BRCA2.

Authors:  Ephrat Levy-Lahad; Amnon Lahad; Mary-Claire King
Journal:  J Natl Cancer Inst       Date:  2014-12-30       Impact factor: 13.506

Review 2.  Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.

Authors:  Brian Drohan; Constance A Roche; James C Cusack; Kevin S Hughes
Journal:  Ann Surg Oncol       Date:  2012-03-17       Impact factor: 5.344

3.  Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.

Authors:  S Paluch-Shimon; F Cardoso; C Sessa; J Balmana; M J Cardoso; F Gilbert; E Senkus
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

4.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Authors:  G Parmigiani; D Berry; O Aguilar
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

5.  A breast cancer prediction model incorporating familial and personal risk factors.

Authors:  Jonathan Tyrer; Stephen W Duffy; Jack Cuzick
Journal:  Stat Med       Date:  2004-04-15       Impact factor: 2.373

6.  Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.

Authors:  Lisa R Susswein; Megan L Marshall; Rachel Nusbaum; Kristen J Vogel Postula; Scott M Weissman; Lauren Yackowski; Erica M Vaccari; Jeffrey Bissonnette; Jessica K Booker; M Laura Cremona; Federica Gibellini; Patricia D Murphy; Daniel E Pineda-Alvarez; Guido D Pollevick; Zhixiong Xu; Gabi Richard; Sherri Bale; Rachel T Klein; Kathleen S Hruska; Wendy K Chung
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

7.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

Authors:  A C Antoniou; A P Cunningham; J Peto; D G Evans; F Lalloo; S A Narod; H A Risch; J E Eyfjord; J L Hopper; M C Southey; H Olsson; O Johannsson; A Borg; B Pasini; B Passini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; L Tryggvadottir; K Syrjakoski; O-P Kallioniemi; H Eerola; H Nevanlinna; P D P Pharoah; D F Easton
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

8.  Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.

Authors:  Kandamurugu Manickam; Adam H Buchanan; Marci L B Schwartz; Miranda L G Hallquist; Janet L Williams; Alanna Kulchak Rahm; Heather Rocha; Juliann M Savatt; Alyson E Evans; Loren M Butry; Amanda L Lazzeri; D'Andra M Lindbuchler; Carroll N Flansburg; Rosemary Leeming; Victor G Vogel; Matthew S Lebo; Heather M Mason-Suares; Derick C Hoskinson; Noura S Abul-Husn; Frederick E Dewey; John D Overton; Jeffrey G Reid; Aris Baras; Huntington F Willard; Cara Z McCormick; Sarath B Krishnamurthy; Dustin N Hartzel; Korey A Kost; Daniel R Lavage; Amy C Sturm; Lauren R Frisbie; T Nate Person; Raghu P Metpally; Monica A Giovanni; Lacy E Lowry; Joseph B Leader; Marylyn D Ritchie; David J Carey; Anne E Justice; H Lester Kirchner; W Andrew Faucett; Marc S Williams; David H Ledbetter; Michael F Murray
Journal:  JAMA Netw Open       Date:  2018-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.